ChartRow logo
$143.72-0.75%
as of market close, Sep 11, 2026
☾ AH
PeersMRNALLYUNHJNJMRKABBV

GILD — Gilead Sciences Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in GILD be worth today? →
GILD returns: By year · By month · By week · Trailing

Key stats

Price data

Price
$143.72
Change YTD
+18.53%
Next earnings
Oct 29, 2026
Market cap
178.2B
Enterprise value
201.8B
Shares outstanding
1.2B
52W low
$108.46
52W high
$157.29
From 52W high
-8.63%
From 52W low
+32.51%
52W range
72%
Beta
0.32

Volume

Rel volume
0.69×
30D volume
6M
30D $ vol
851.2M

Fundamentals

Sales (ttm)
30.5B
Sales/share
$24.56
EPS (ttm)
-$2.59
FCF (ttm)
12.9B
FCF/share
$10.44
Book value/share
$9.54
Net margin
-10.64%
ROE
-27.39%
ROA
-6.56%
Debt / equity
2.01×
Current ratio
1.27

Growth (CAGR, ttm) · 10Y

Sales
+5.53%+3.61%+2.72%-0.61%
FCF
+38.18%+13.18%+8.85%-3.34%
Shares
-0.07%-0.16%-0.22%-0.62%

Per-share growth (CAGR, ttm) · 10Y

Sales/share
+5.60%+3.78%+2.94%+0.01%
FCF/share
+38.27%+13.37%+9.09%-2.73%
Book value/share
-39.85%-17.48%-9.50%-2.08%
Dividend/share
+3.21%+2.85%+2.98%+6.23%
Price
+21.96%+23.10%+15.14%+6.29%
Total return
+25.14%+27.21%+19.42%+10.12%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
-55.5×
P/OI (ttm)
15.1×
Fwd P/E
14.8×
P/S (ttm)
5.9×
P/B (mrq)
15.1×
P/FCF (ttm)
13.8×
EV/EBITDA (fy)
736.5×
EV/Sales (ttm)
6.6×
FCF yield (ttm)
7.26%
Dividend yield (fwd)
2.24%
Dividend/share (fwd)
$3.22
Buyback yield (realized, 1y)
0.07%
Shareholder yield (realized, 1y)
3.03%
Buyback yield (cash, ttm)
0.64%
Shareholder yield (cash, ttm)
2.92%

Vs own 10Y history

P/E
35th
P/OI
63rd
P/S
98th
P/B
99th
P/FCF
87th

Bar = where today’s multiple sits in GILD’s own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

1D
-0.75%
5D
-4.96%
1M
+5.78%
3M
+14.93%
YTD
+18.53%
1Y
+27.95%
5Y
+138.45%

Financial statements

Open full GILD financials →
Loading financial statements…
TickerName1M1D
LLYEli Lilly and Company-8.44%-0.65%
JNJJohnson & Johnson+2.31%-0.29%
ABBVAbbVie Inc.+3.36%+0.83%
MRKMerck & Co. Inc.+8.28%-0.54%
UNHUnitedHealth Group Incorporated Common Stock (DE)-6.53%-2.37%
TMOThermo Fisher Scientific Inc.+1.13%+1.10%
AMGNAmgen Inc.-8.80%-1.34%
ABTAbbott Laboratories-8.08%-1.36%

Gilead Sciences Inc. (GILD) trades at $143.72 with a live price and an interactive chart covering 34+ years of daily price history, plus key valuation metrics. ChartRow also publishes GILD’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full GILD financial statements →